{"id":"vaxzevria-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"},{"rate":"null","effect":"Muscle pain"},{"rate":"null","effect":"Chills"}]},"_chembl":{"chemblId":"CHEMBL2108573","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This is achieved through the introduction of a weakened or inactivated form of the virus, which triggers an immune response without causing the disease itself. The immune system then produces antibodies and immune cells that can recognize and attack the virus if it enters the body in the future.","oneSentence":"Vaxzevria Vaccine works by stimulating the body's immune system to produce a specific response against the SARS-CoV-2 virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:40:16.430Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"COVID-19 prevention"}]},"trialDetails":[{"nctId":"NCT05110911","phase":"","title":"Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2020-04-02","conditions":"Influenza, Human, SARS-CoV-2 Infection","enrollment":1500},{"nctId":"NCT04894435","phase":"PHASE2","title":"Mix and Match of the COVID-19 Vaccine for Safety and Immunogenicity","status":"ACTIVE_NOT_RECRUITING","sponsor":"Canadian Immunization Research Network","startDate":"2021-05-20","conditions":"COVID-19","enrollment":669},{"nctId":"NCT05387317","phase":"PHASE3","title":"Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)","status":"WITHDRAWN","sponsor":"Murdoch Childrens Research Institute","startDate":"2024-04","conditions":"COVID-19","enrollment":""},{"nctId":"NCT05543356","phase":"PHASE3","title":"COVID-19 Fourth Dose Study in Australia","status":"WITHDRAWN","sponsor":"Murdoch Childrens Research Institute","startDate":"2022-05-02","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04826770","phase":"","title":"Adaptive Immune Response to COVID-19 Vaccination","status":"UNKNOWN","sponsor":"University Medicine Greifswald","startDate":"2021-01-06","conditions":"SARS-CoV-2 Vaccination","enrollment":70},{"nctId":"NCT05188677","phase":"PHASE3","title":"Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in Adults","status":"COMPLETED","sponsor":"Clover Biopharmaceuticals AUS Pty","startDate":"2022-06-13","conditions":"COVID-19","enrollment":1831},{"nctId":"NCT05208983","phase":"","title":"SafeTy and Efficacy of Preventative CoVID Vaccines","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-05-06","conditions":"COVID-19 Virus Infection, Vaccine Response","enrollment":1286},{"nctId":"NCT05618548","phase":"","title":"Vaccination Against COVID-19 in Pregnant and Lactating Women in Belgium","status":"UNKNOWN","sponsor":"Universiteit Antwerpen","startDate":"2021-03-01","conditions":"Covid19","enrollment":110},{"nctId":"NCT05083065","phase":"","title":"Evaluation of Menstrual Irregularities and Abnormal Uterine Bleeding After Covid-19 Vaccine","status":"COMPLETED","sponsor":"Università degli Studi dell'Insubria","startDate":"2021-09-10","conditions":"COVID-19, Vaccine, Menstrual Irregularity","enrollment":369},{"nctId":"NCT05534035","phase":"PHASE3","title":"Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older","status":"UNKNOWN","sponsor":"Everest Medicines (Singapore) Pte. Ltd.","startDate":"2023-02-03","conditions":"SARS-CoV-2 Infection","enrollment":450},{"nctId":"NCT05124483","phase":"PHASE2","title":"Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)","status":"UNKNOWN","sponsor":"University Medical Center Groningen","startDate":"2022-04-21","conditions":"COVID-19","enrollment":600},{"nctId":"NCT05378191","phase":"PHASE2","title":"Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First Dose","status":"UNKNOWN","sponsor":"Instituto de Investigación Hospital Universitario La Paz","startDate":"2021-04-22","conditions":"Covid19","enrollment":600},{"nctId":"NCT04834869","phase":"","title":"COVID-19 Vaccines Safety Tracking (CoVaST)","status":"RECRUITING","sponsor":"Masaryk University","startDate":"2021-04-01","conditions":"Adverse Reaction to Vaccine, COVID19 Vaccine","enrollment":30000},{"nctId":"NCT05145348","phase":"","title":"Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.","status":"UNKNOWN","sponsor":"UMC Utrecht","startDate":"2021-02-03","conditions":"Down Syndrome, SARS-CoV-2 Vaccination","enrollment":640},{"nctId":"NCT04907331","phase":"PHASE2","title":"Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2","status":"UNKNOWN","sponsor":"Medical University Innsbruck","startDate":"2021-05-10","conditions":"SARS-CoV2 Infection","enrollment":3000},{"nctId":"NCT04885764","phase":"PHASE2, PHASE3","title":"Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams University","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2021-02-23","conditions":"Covid19","enrollment":4000}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"INTERSTITIAL LUNG DISEASE"}],"_approvalHistory":[],"publicationCount":39,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Vaxzevria Vaccine","genericName":"Vaxzevria Vaccine","companyName":"Clover Biopharmaceuticals AUS Pty","companyId":"clover-biopharmaceuticals-aus-pty","modality":"Biologic","firstApprovalDate":"","aiSummary":"Vaxzevria Vaccine works by stimulating the body's immune system to produce a specific response against the SARS-CoV-2 virus. Used for COVID-19 prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}